LOUISVILLE, Ky. — A sublingual film delivered sufficient concentrations of epinephrine to the blood faster than autoinjectors, according to a study presented at the American College of Asthma & ...

Please provide your email address to receive an email when new articles are posted on . Subjects had two doses each of Belhaven Biopharma’s BBP01 and intramuscular epinephrine. Subjects had faster and ...

Anaphylm, epinephrine sublingual film is a better solution to existing and in-development epinephrine formulations to treat anaphylaxis, a $1 billion/year market. Pharmacokinetic studies have shown ...

Commences initial Phase 3 study with first orally delivered epinephrine prodrug candidate Reaffirms topline data anticipated in first quarter 2024 The two-part, Phase 3, single-center, open-label, ...

The MarketWatch News Department was not involved in the creation of this content. Belhaven's Investigational New Drug (IND) Application Receives FDA Authorization to Proceed RALEIGH, NORTH CAROLINA / ...

ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office. "I was pretty shocked the first time I used it ...

Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated ...

RALEIGH, N.C.--(BUSINESS WIRE)--Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat ...

Aquestive Therapeutics (NASDAQ:AQST) is trading ~6% higher in the premarket Friday after the commercial-stage pharmaceutical company announced positive topline data from its Part 1 of the EPIPHAST ...

Belhaven's Investigational New Drug (IND) Application Receives FDA Authorization to Proceed RALEIGH, NORTH CAROLINA / ACCESS Newswire / October 8, 2025 / Belhaven Biopharma, a leader in developing ...